Analyst Revise These Stock Price Targets Feb 13th

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on February 13th:

Mattel (NASDAQ:MAT):

UBS reiterated its rating of Buy for this company and changed its price target from $33 to $36.

LyondellBasell (NYSE:LYB):

UBS reiterated its rating of Buy for this company and changed its price target from $47 to $50. Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $43 to $55.

IDEX Corp (NYSE:IEX):

UBS reiterated its rating of Neutral for this company and changed its price target from $41 to $45.

Flowserve (NYSE:FLS):

UBS reiterated its rating of Buy for this company and changed its price target from $111 to $130.

Actuant (NYSE:ATU):

UBS reiterated its rating of Buy for this company and changed its price target from $26 to $31.

Tech Data (NASDAQ:TECD):

Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $48 to $54.

NJ Resources (NYSE:NJR):

Barclays Capital reiterated its rating of Underweight for this company and changed its price target from $43 to $46.

IPG Photonics (NASDAQ:IPGP):

Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $50 to $54.

Dupont Fabros Tech (NYSE:DFT):

Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $29 to $26.

DIRECTV (NASDAQ:DTV):

Barclays Capital reiterated its rating of Overweight for this company and changed its price target from $59 to $54.

Dell (NASDAQ:DELL): The pricing “sweet spot” of around $599-$699 which is expected to drive higher demand of “ultrabook” notebook PCs is not expected to be met by most vendors until 2013, according to industry sources reporting to DigiTimes.

Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $16 to $19.

Buckeye Partners (NYSE:BPL):

Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $71 to $68.

Arch Coal (NYSE:ACI):

Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $22 to $16. Dahlman Rose reiterated its rating of Buy for this company and changed its price target from $25 to $20. FBR Capital reiterated its rating of Outperform for this company and changed its price target from $23 to $20.

Alliant Energy (NYSE:LNT):

Barclays Capital reiterated its rating of Equal Weight for this company and changed its price target from $42 to $44.

Regeneron Pharms (NASDAQ:REGN): Regeneron has filed an sBLA for EYLEA in central retinal vein occlusion, or CRVO, in the U.S., and was granted a Prescription Drug User Free Act, or PDUFA, date of September 23, 2012. Bayer HealthCare plans to submit a similar regulatory application outside the U.S. in 2012 or early 2013.

Brean Murray reiterated its rating of Buy for this company and changed its price target from $100 to $120.

Agnico-Eagle Mines (NYSE:AEM):

RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $66 to $43.

Apollo Global Management (NASDAQ:APO): A number of private equity firms are focused on the U.S. oil patch as the look for growth, reports the Wall Street Journal. Last year alone private equity firms completed $24.8B of energy deals, and the trend is continuing, reports the Wall Street Journal.

Compass Point reiterated its rating of Buy for this company and changed its price target from $15.5 to $17.5.

Pier 1 Imports (NYSE:PIR):

Longbow reiterated its rating of Buy for this company and changed its price target from $16 to $19.

Flowers Foods (NYSE:FLO):

Longbow reiterated its rating of Buy for this company and changed its price target from $24 to $22.

Intl Paper (NYSE:IP):

Longbow reiterated its rating of Buy for this company and changed its price target from $36 to $38.

Lance (NASDAQ:LNCE):

RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $24 to $22.

PharMerica (NYSE:PMC):

RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $24 to $22.

Lions Gate Entertainment (NYSE:LGF):

RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $7 to $1250.

Laboratory Corp (NYSE:LH):

RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $84 to $95.

Biomarin Pharm (NASDAQ:BMRN):

RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $36 to $40.

KB Home (NYSE:KBH):

RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $9 to $16.

Visa (NYSE:V):

Argus reiterated its rating of Buy for this company and changed its price target from $110 to $130.

Coca-Cola Ent (NYSE:CCE):

Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $30 to $32.

Monster Beverage (MNST):

Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $95 to $123.

Baidu.com (NASDAQ:BIDU):

Brean Murray reiterated its rating of Buy for this company and changed its price target from $185 to $200.

Techtarget (NASDAQ:TTGT):

The Benchmark Company reiterated its rating of Buy for this company and changed its price target from $8 to $10.

Cameco (NYSE:CCJ):

Dahlman Rose reiterated its rating of Buy for this company and changed its price target from $32 to $30.

Home Properties (NYSE:HME):

Wunderlich reiterated its rating of Buy for this company and changed its price target from $75 to $68.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Wall St. Cheat Sheet Staff at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com